Iconovo is a developer of inhalers for drugs that treat conditions such as asthma and COPD.
Iconovo has raised $51K in total funding. The most recent round was Grant. The last funding was announced in March 2023.
Iconovo's investors include Bill & Melinda Gates Foundation, Swelife.
Iconovo is headquartered in Lund, Sweden.
Iconovo is a developer of inhalers for drugs that treat conditions such as asthma and COPD.
Iconovo is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Iconovo — Funding & Investors." VCBacked, March 31, 2023, https://www.vcbacked.co/company/iconovo. Accessed September 30, 2026.
VCBacked. (2023). Iconovo — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/iconovo
{{cite web |title=Iconovo — Funding & Investors |url=https://www.vcbacked.co/company/iconovo |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated